Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

JCR Pharmaceuticals Co Ltd (4552)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
806.0 -7.0    -0.86%
02/05 - Closed. Currency in JPY ( Disclaimer )
  • Volume: 415,200
  • Bid/Ask: 805.0 / 807.0
  • Day's Range: 796.0 - 811.0
Type:  Equity
Market:  Japan
ISIN:  JP3701000006 
JCR Pharmaceuticals 806.0 -7.0 -0.86%

JCR Pharmaceuticals Co Ltd Company Profile

 
Get an in-depth profile of JCR Pharmaceuticals Co Ltd, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryPharmaceuticals
SectorHealthcare
Employees

879

Equity Type

ORD

JCR Pharmaceuticals Co., Ltd., together with its subsidiaries, engages in the research, development, manufacture, import and export, and sale of pharmaceutical products, regenerative medicines, and drug substances in Japan. It offers various therapeutic products, including GROWJECT used for the treatment of growth hormone deficiency and short stature; IZCARGO to treat Mucopolysaccharidosis type II; Agalsidase Beta BS I.V. Infusion used for the treatment of Fabry disease; and TEMCELL HS Inj used to treat acute graft-versus-host disease. The company develops Epoetin Alfa BS and Darbepoetin Alfa BS Injections for the treatment of renal anemia. In addition, it sells, imports, and exports medical devices and laboratory instruments; and purchases and sells medical and research equipment. The company has a collaboration agreement with Angelini Pharma for the development of novel biologic therapies; and a. joint research agreement with Modalis Therapeutics Corporation to evaluate the drug delivery technology of the gene therapy to the central nervous system (CNS) assuming CNS diseases as a target. JCR Pharmaceuticals Co., Ltd. was incorporated in 1975 and is headquartered in Ashiya, Japan.

Contact Information

Address 3-19 Kasuga-cho
Ashiya, 659-0021
Japan
Phone 81 7 9732 8591
Fax -

Top Executives

Name Age Since Title
Toru Ashida - 2015 Senior VP of Sales & Administration, Executive Director of Sales Division and Director
Shin Ashida 78 2005 Chairman, CEO & President
Kazumasa Oizumi 76 2013 Outside Audit & Supervisory Board Member
Toshihiro Ishikiriyama 71 2015 Independent Outside Director
Yuko Hayashi 58 - Independent Outside Director
Kenjiro Miyatake 85 2013 Outside Audit & Supervisory Board Member
Takeshi Komura 84 2017 Outside Audit & Supervisory Board Member
Philippe Fauchet 66 - Independent Outside Director
Takashi Suetsuna 74 - Independent Outside Director
Kazuhiko Yamada 76 2006 Outside Audit & Supervisory Board Member
Shuichi Tani 84 2017 Outside Audit & Supervisory Board Member
Yutaka Atomi 79 2022 Independent Outside Director
Marc Dunoyer 71 2023 Independent Outside Director
Toshihide Yoda 60 - Independent Outside Director
Hiroyuki Sonoda 45 2018 VP of Research & Corporate Strategy, Executive Director of Research Division and Director
Mathias Schmidt 55 2020 VP of Clinical Development, Business Development & IR Fields and Senior Executive Director
Yoshio Hiyama 64 2021 Sr. Exec. Director, Director of Regulatory Affairs Dept. & Director
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

4552 Comments

Write your thoughts about JCR Pharmaceuticals Co Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email